Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGS - Delayed Quote USD

TherapeuticsMD, Inc. (TXMD)

1.4200
+0.0300
+(2.16%)
At close: May 2 at 4:00:01 PM EDT
1.4900
+0.07
+(4.93%)
After hours: May 2 at 7:30:16 PM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Marlan D. Walker J.D. Chief Executive Officer 759.17k -- 1975
Mr. Joseph A. Ziegler Principal Financial & Accounting Officer 120k -- 1974
Mr. Douglas Steelman Vice President of Market Access -- -- --

TherapeuticsMD, Inc.

951 Yamato Road
Suite 220
Boca Raton, FL 33431
United States
561 961 1900 https://www.therapeuticsmd.com
Sector: 
Healthcare
Full Time Employees: 
1

Description

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Corporate Governance

TherapeuticsMD, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 5. The pillar scores are Audit: 9; Board: 6; Shareholder Rights: 3; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 8, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC

TherapeuticsMD, Inc. Earnings Date

Recent Events

April 30, 2025 at 12:00 AM UTC

10-K/A: Periodic Financial Reports

April 9, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

March 27, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

December 5, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

October 25, 2024 at 12:00 AM UTC

ARS: Annual Report to Shareholders

September 20, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

June 14, 2024 at 12:00 AM UTC

AW: Withdrawal of amendment to a registration statement filed under the Securities Act

May 10, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers

Waiting for permission
Allow microphone access to enable voice search

Try again.